SCR-1481B1 Metatinib anhydrous; c-Met inhibitor 2,99.82%
产品编号:Bellancom-18711A| CAS NO:1174161-86-4| 分子式:C32H40ClF2N6O13P| 分子量:821.12
SCR-1481B1 (c-Met inhibitor 2) 有效作用于依赖Met激活的癌症,且抑制VEGFR。
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
SCR-1481B1 Metatinib anhydrous; c-Met inhibitor 2
| 产品介绍 | SCR-1481B1 (Metatinib anhydrous) 有效作用于依赖 Met 激活的癌症,且抑制 VEGFR。 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 生物活性 | SCR-1481B1 (Metatinib anhydrous) is a potent compound that has activity against cancers dependent upon Met activation and also has activity against cancers as a VEGFR inhibitor. | ||||||||||||||||
| 体外研究 |
More details please refer to Patent WO 2009094417 A1. 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
| 体内研究 | |||||||||||||||||
| 体内研究 | |||||||||||||||||
| 性状 | Solid | ||||||||||||||||
| 溶解性数据 |
In Vitro:
DMSO : ≥ 100 mg/mL (121.78 mM) * "≥" means soluble, but saturation unknown. 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
*以上所有助溶剂都可在 西域 网站选购。
| ||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
| 储存方式 |
4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
| 参考文献 |
[1]. Robert M. Borzilleri, et al. 4-pyridinone compounds and their use for cancer. WO/2009094417/A1.
有竞争力的价格匹配竞争对手的价格
极速物流效率为先
技术支持专业经验 贴心服务
现货库存50000+库存
浙公网安备 33010802013016号